Multifaceted nano-DEV-IL for sustained release of IL-12 to avert the immunosuppressive tumor microenvironment and IL-12-associated toxicities A Barnwal, S Ganguly, J Bhattacharyya ACS Applied Materials & Interfaces 15 (16), 20012-20026, 2023 | 6 | 2023 |
Repurposing Ponatinib as a PD-L1 Inhibitor Revealed by Drug Repurposing Screening and Validation by In Vitro and In Vivo Experiments A Barnwal, S Das, J Bhattacharyya ACS Pharmacology & Translational Science 6 (2), 281-289, 2023 | 6 | 2023 |
SARS-CoV-2 Spike Protein-Activated Dendritic Cell-Derived Extracellular Vesicles Induce Antiviral Immunity in Mice A Barnwal, B Basu, A Tripathi, N Soni, D Mishra, A Banerjee, R Kumar, ... ACS Biomaterials Science & Engineering 8 (12), 5338-5348, 2022 | 6 | 2022 |
Tumor Antigen-primed dendritic cell-derived exosome synergizes with colony stimulating Factor-1 receptor inhibitor by modulating the Tumor Microenvironment and systemic immunity A Barnwal, V Gaur, A Sengupta, W Tyagi, S Das, J Bhattacharyya ACS Biomaterials Science & Engineering 9 (11), 6409-6424, 2023 | 4 | 2023 |
Ponatinib delays the growth of solid tumours by remodelling immunosuppressive tumour microenvironment through the inhibition of induced PD-L1 expression A Barnwal, R Tamang, S Das, J Bhattacharyya British Journal of Cancer 129 (6), 1007-1021, 2023 | 4 | 2023 |
AJ17 potentiates agonist CD40 antibody efficacy and attenuates agonist CD40 induced PD-L1 expression and associated toxicity in murine tumor models V Gaur, A Barnwal, B Ateeq, J Bhattacharyya Cancer Research 83 (7_Supplement), 4128-4128, 2023 | | 2023 |
Inhibition of CSF1R enhances the antitumor efficacy of DC derived exosomes by modulating immunosuppressive tumor microenvironment A Barnwal, J Bhattacharyya, B Ateeq Cancer Research 82 (12_Supplement), 5585-5585, 2022 | | 2022 |